| P/E (FY) | 29.5 | Sales (TTM) | $608.9M |
| Earnings (TTM) | $68.6M | ROE | 17.82% |
| Net Margin | 11.33% | ROIC | 14.46% |
| Debt / Equity | 0.32 | TD / EBITDA | 1.21 |
| EPS Growth 3Y | 17.09% | Sales Growth 3Y | 19.46% |
UFP Technologies designs and manufactures solutions for medical devices, sterile packaging, and engineered custom products in the United States. Its medical offerings include surgical drapes, wound care, infection prevention, device packaging, orthopedic and cardiac implant components, catheter coils, and biopharma manufacturing. It also makes protective packaging for firearms, drones, weapon systems, and electronics, along with cushion packaging, acoustic and thermal insulation, and filtration components.
| Market Cap | $2.00B | Trading Days | 5292 |
| 52W High | 279.49 |
| 52W Low | 174.00 |
| % Off High | −7.66% |
| YTD | 16.23% | 1Y | 5.46% |
| 3Y | 34.92% | 5Y | 327.55% |
| 10Y | 1011.41% | Since incept. (ann.) | 22.84% |
Reportable 100%
| Ann. Volatility (1Y) | 45.30% | Ann. Volatility (3Y) | 48.36% |
| Sharpe (1Y) | 0.35 | Sharpe (3Y) | 0.45 |
| Max Drawdown (1Y) | −30.69% | Max Drawdown (3Y) | −48.31% |
| Beta (3Y, vs SPY) | 1.91 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| ATRC | AtriCure, Inc. | $2.02B | — |
| NVCR | NovoCure Ltd | $1.90B | — |
| HTFL | Heartflow, Inc. | $2.21B | — |
| LMAT | LEMAITRE VASCULAR INC | $2.34B | 40.6 |
| PLSE | PULSE BIOSCIENCES, INC. | $2.45B | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.54B | — |
| INSP | Inspire Medical Systems, Inc. | $1.50B | 10.6 |
| ATEC | Alphatec Holdings, Inc. | $1.41B | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.40B | — |
| AORT | ARTIVION, INC. | $1.31B | 128.6 |
| TNDM | TANDEM DIABETES CARE INC | $1.22B | — |
| IRMD | IRADIMED CORP | $1.21B | 54.2 |
